The aim of the present study was to formulate lornoxicam into rectal suppositories as a new dosage form, to avoid its reported gastric irritation and to provide a rapid onset of action for children. Suppositories were prepared using fatty bases namely; witepsol H-15, suppocire AML, CM, witepsol E-75 and water soluble bases; mixtures of poly(ethylene glycol), PEGs, with different molecular weights. The prepared suppositories were investigated for their weight variation, drug content, melting point, fracture point, disintegration time and in-vitro release pattern. Moreover, aging study was performed both at room temperature and in refrigerator for 6 month. In-vivo study was also carried out in rabbits and the pharmacokinetic parameters were estimated. The prepared suppositories complied with the USP 34 pharmacopoeial requirements and PEGs-based suppositories released significantly higher amounts of lornoxicam compared with fatty bases (p0.05, ANOVA/Dunnett). Furthermore, lornixocam in selected formulations was found to be stable in both fatty and PEGs bases after the aging study. Formulation No. 5 showed a higher Cmax of 1.832±0.35 μg/ml, short tmax of 1 hr and absolute bioavailability of 80.1%. These findings suggest that lornoxicam was successfully formulated into rectal suppositories with a higher bioavailability.

The aim of this study was to develop liposomal-based (LBGF) and micro-emulsion-based (MBGF) gel formulations of croconazole to compare their topical delivery potential. Conventional gels were also prepared using various polymers such as sodium carboxymethyl cellulose (SCMC), Poloxamer 407, Carbopol 971P and chitosan. The in vitro release of croconazole from conventional gel formulations, LBGF and MBGF were carried out using cellophane membrane as permeation membrane. However, in vitro skin permeations studies of all formulations were carried out using rat skin. The results of the drug release/skin permeation studies indicated that the highest release was obtained from SCMC followed by chitosan, Poloxamer 407 and finally Carbopol 971P gel. Therefore, liposomes and micro-emulsions were loaded on Carbopol 971P gel. The drug release and skin permeation of croconazole from different LBGF and MBGF showed that MBGF had superior release/permeation than LBGF. MBGF having ethanol as co-surfactant showed higher release/permeation of drug than MBGF-containing propylene glycol. The analysis of data according to different kinetic models indicated that the release of drug from different LBGF and MBGF followed the Higuchi model. The antimicrobial activity of the different LBGF and MBGF of croconazole was carried out by measuring the inhibition zone (mm) and compared by the effect of miconazole cream as control. The different LBGF and MBGF showed an excellent activity against different species of fungi as compared with miconazole cream. Overall, these results indicated that developed LBGF and MBGF could have great potential for topical delivery of croconazole.

The aim of this study was to develop liposomal-based (LBGF) and micro-emulsion-based (MBGF) gel formulations of croconazole to compare their topical delivery potential. Conventional gels were also prepared using various polymers such as sodium carboxymethyl cellulose (SCMC), Poloxamer 407, Carbopol 971P and chitosan. The in vitro release of croconazole from conventional gel formulations, LBGF and MBGF were carried out using cellophane membrane as permeation membrane. However, in vitro skin permeations studies of all formulations were carried out using rat skin. The results of the drug release/skin permeation studies indicated that the highest release was obtained from SCMC followed by chitosan, Poloxamer 407 and finally Carbopol 971P gel. Therefore, liposomes and micro-emulsions were loaded on Carbopol 971P gel. The drug release and skin permeation of croconazole from different LBGF and MBGF showed that MBGF had superior release/permeation than LBGF. MBGF having ethanol as co-surfactant showed higher release/permeation of drug than MBGF-containing propylene glycol. The analysis of data according to different kinetic models indicated that the release of drug from different LBGF and MBGF followed the Higuchi model. The antimicrobial activity of the different LBGF and MBGF of croconazole was carried out by measuring the inhibition zone (mm) and compared by the effect of miconazole cream as control. The different LBGF and MBGF showed an excellent activity against different species of fungi as compared with miconazole cream. Overall, these results indicated that developed LBGF and MBGF could have great potential for topical delivery of croconazole.

The aim of this study was to measure and correlate the temperature dependent solubility data of tadalafil (TDL) in water, ethanol, propylene glycol (PG), polyethylene glycol-400 (PEG-400), and Transcutol from (298.15 to 333.15) K at atmospheric pressure using the shake flask method. The experimental solubilities were regressed by Apelblat equation with a relative deviation in the range of (1.20 to 5.74) % in all solvents investigated at (298.15 to 333.15) K. The root mean square deviation between experimental and calculated solubility was observed less than 1.10 in all solvents investigated. The correlation coefficients in water, ethanol, PG, PEG-400, and Transcutol were observed in the range of 0.997 to 0.999. The solubility of TDL was found to be increased with an increase in temperature in all solvents investigated. The mole fraction solubility of TDL was found to be higher in PEG-400 (1.86•10−2 at 298.15 K) and Transcutol (8.76•10−3 at 298.15 K) as compared to water (5.74•10−7 at 298.15 K), ethanol (1.77• 10−4 at 298.15 K) and PG (4.1•10−4 at 298.15 K).

The aim of this study was to measure and correlate the temperature dependent solubility data of tadalafil (TDL) in water, ethanol, propylene glycol (PG), polyethylene glycol-400 (PEG-400), and Transcutol from (298.15 to 333.15) K at atmospheric pressure using the shake flask method. The experimental solubilities were regressed by Apelblat equation with a relative deviation in the range of (1.20 to 5.74) % in all solvents investigated at (298.15 to 333.15) K. The root mean square deviation between experimental and calculated solubility was observed less than 1.10 in all solvents investigated. The correlation coefficients in water, ethanol, PG, PEG-400, and Transcutol were observed in the range of 0.997 to 0.999. The solubility of TDL was found to be increased with an increase in temperature in all solvents investigated. The mole fraction solubility of TDL was found to be higher in PEG-400 (1.86•10−2 at 298.15 K) and Transcutol (8.76•10−3 at 298.15 K) as compared to water (5.74•10−7 at 298.15 K), ethanol (1.77• 10−4 at 298.15 K) and PG (4.1•10−4 at 298.15 K).

The combination of certain non-sedating antihistamines (NSA) such as fexofenadine (FXD), ketotifen (KET) and loratadine (LOR) with pseudoephedrine (PSE) or acetaminophen (ACE) is widely used in the treatment of allergic rhinitis, conjunctivitis and chronic urticaria. A rapid, simple, selective and precise densitometric method was developed and validated for simultaneous estimation of six synthetic binary mixtures and their pharmaceutical dosage forms. The method employed thin layer chromatography aluminum plates precoated with silica gel G 60 F254 as the stationary phase. The mobile phases chosen for development gave compact bands for the mixtures FXD–PSE (I), KET–PSE (II), LOR–PSE (III), FXD–ACE (IV), KET–ACE (V) and LOR–ACE (VI) [Retardation factor (Rf) values were (0.20, 0.32), (0.69, 0.34), (0.79, 0.13), (0.36, 0.70), (0.51, 0.30) and (0.76, 0.26), respectively]. Spectrodensitometric scanning integration was performed at 217, 218, 218, 233, 272 and 251 nm for the mixtures I–VI, respectively. The linear regression data for the calibration plots showed an excellent linear relationship. The method was validated for precision, accuracy, robustness and recovery. Limits of detection and quantitation were calculated. Statistical analysis proved that the method is reproducible and selective for the simultaneous estimation of these binary mixtures.

The combination of certain non-sedating antihistamines (NSA) such as fexofenadine (FXD), ketotifen (KET) and loratadine (LOR) with pseudoephedrine (PSE) or acetaminophen (ACE) is widely used in the treatment of allergic rhinitis, conjunctivitis and chronic urticaria. A rapid, simple, selective and precise densitometric method was developed and validated for simultaneous estimation of six synthetic binary mixtures and their pharmaceutical dosage forms. The method employed thin layer chromatography aluminum plates precoated with silica gel G 60 F254 as the stationary phase. The mobile phases chosen for development gave compact bands for the mixtures FXD–PSE (I), KET–PSE (II), LOR–PSE (III), FXD–ACE (IV), KET–ACE (V) and LOR–ACE (VI) [Retardation factor (Rf) values were (0.20, 0.32), (0.69, 0.34), (0.79, 0.13), (0.36, 0.70), (0.51, 0.30) and (0.76, 0.26), respectively]. Spectrodensitometric scanning integration was performed at 217, 218, 218, 233, 272 and 251 nm for the mixtures I–VI, respectively. The linear regression data for the calibration plots showed an excellent linear relationship. The method was validated for precision, accuracy, robustness and recovery. Limits of detection and quantitation were calculated. Statistical analysis proved that the method is reproducible and selective for the simultaneous estimation of these binary mixtures.

The combination of certain non-sedating antihistamines (NSA) such as fexofenadine (FXD), ketotifen (KET) and loratadine (LOR) with pseudoephedrine (PSE) or acetaminophen (ACE) is widely used in the treatment of allergic rhinitis, conjunctivitis and chronic urticaria. A rapid, simple, selective and precise densitometric method was developed and validated for simultaneous estimation of six synthetic binary mixtures and their pharmaceutical dosage forms. The method employed thin layer chromatography aluminum plates precoated with silica gel G 60 F254 as the stationary phase. The mobile phases chosen for development gave compact bands for the mixtures FXD–PSE (I), KET–PSE (II), LOR–PSE (III), FXD–ACE (IV), KET–ACE (V) and LOR–ACE (VI) [Retardation factor (Rf) values were (0.20, 0.32), (0.69, 0.34), (0.79, 0.13), (0.36, 0.70), (0.51, 0.30) and (0.76, 0.26), respectively]. Spectrodensitometric scanning integration was performed at 217, 218, 218, 233, 272 and 251 nm for the mixtures I–VI, respectively. The linear regression data for the calibration plots showed an excellent linear relationship. The method was validated for precision, accuracy, robustness and recovery. Limits of detection and quantitation were calculated. Statistical analysis proved that the method is reproducible and selective for the simultaneous estimation of these binary mixtures.

The combination of certain non-sedating antihistamines (NSA) such as fexofenadine (FXD), ketotifen (KET) and loratadine (LOR) with pseudoephedrine (PSE) or acetaminophen (ACE) is widely used in the treatment of allergic rhinitis, conjunctivitis and chronic urticaria. A rapid, simple, selective and precise densitometric method was developed and validated for simultaneous estimation of six synthetic binary mixtures and their pharmaceutical dosage forms. The method employed thin layer chromatography aluminum plates precoated with silica gel G 60 F254 as the stationary phase. The mobile phases chosen for development gave compact bands for the mixtures FXD–PSE (I), KET–PSE (II), LOR–PSE (III), FXD–ACE (IV), KET–ACE (V) and LOR–ACE (VI) [Retardation factor (Rf) values were (0.20, 0.32), (0.69, 0.34), (0.79, 0.13), (0.36, 0.70), (0.51, 0.30) and (0.76, 0.26), respectively]. Spectrodensitometric scanning integration was performed at 217, 218, 218, 233, 272 and 251 nm for the mixtures I–VI, respectively. The linear regression data for the calibration plots showed an excellent linear relationship. The method was validated for precision, accuracy, robustness and recovery. Limits of detection and quantitation were calculated. Statistical analysis proved that the method is reproducible and selective for the simultaneous estimation of these binary mixtures.

Two separation methods were developed for the determination of S- and R-perindopril tert-butylamine (erbumine salt) (PER): high performance liquid chromatography (HPLC) and capillary electrophoresis (CE). The HPLC method uses a chiral stationary phase (CSP), ChiraDex column constituting -cyclodextrin chemically bonded to spherical silica gel particles. The mobile phase consisted of phosphate buffer (50 mM, pH 3.0) and acetonitrile (45 : 55 v/v). The flow rate was 1.0 mL min1 and the detection wavelength was 210 nm. In CE, 2-hydroxylpropyl--cyclodextrin (10 mM) was used as a chiral selector. It was added to the background buffer composed of phosphate buffer (100 mM, pH 7.0) and methanol (15% v/v). The applied voltage was 15 kV and the detection was carried out using a diode array detector. All factors affecting the chromatographic or electrophoretic separations were studied and optimized. The linear concentrations ranged from 5–150 and 25–800 µg mL1 with detection limits of 2.3 and 14.7 µg mL1 for HPLC and CE methods, respectively. The methods were validated according to ICH and USP guidelines. The suggested methods were applied for the determination of S-PER in bulk powder and commercial tablets containing PER erbumine racemate.